Phibro Animal Health Corporation (PAHC)
USD 17.91
(2.34%)
USD 17.91
(2.34%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 87.59 Million | 13.31 Million | 31.64 Million | 48.3 Million | 59.34 Million | 47.16 Million |
| Net Income | 2.41 Million | 32.6 Million | 49.17 Million | 54.38 Million | 33.55 Million | 54.71 Million |
| Depreciation & Amortization | 36.17 Million | 34.01 Million | 32.7 Million | 31.88 Million | 32.34 Million | 27.56 Million |
| Deferred income taxes | -12.04 Million | -2.83 Million | -806 Thousand | -2.18 Million | 8.12 Million | -105 Thousand |
| Stock-based compensation | 475 Thousand | - | - | 1.12 Million | 2.25 Million | 2.25 Million |
| Change in working capital | 33.11 Million | -41.13 Million | -44.63 Million | -29.86 Million | -13.65 Million | -35.94 Million |
| Other non-cash items | 94.32 Million | 1.06 Million | -4.78 Million | -7.04 Million | -3.27 Million | -1.31 Million |
| Investing Cash Flow | -48.19 Million | -74.01 Million | -22.58 Million | -18.58 Million | -120.39 Million | -14.13 Million |
| Investments in PPE | -41.23 Million | -51.79 Million | -37.04 Million | -29.32 Million | -34.04 Million | -29.89 Million |
| Acquisitions | -3.28 Million | 51.79 Million | -13.51 Million | 29.32 Million | -54.54 Million | -9.83 Million |
| Investment purchases | -65.52 Million | -40 Million | -64.1 Million | -74 Million | -80 Million | -34 Million |
| Sales/Maturities of investments | 61.52 Million | 17 Million | 91.45 Million | 86 Million | 49 Million | 60 Million |
| Other Investing Activities | 326 Thousand | -51.01 Million | 620 Thousand | -30.58 Million | -796 Thousand | -404 Thousand |
| Financing Cash Flow | -6.76 Million | 26.98 Million | 16.34 Million | -16.99 Million | 40.93 Million | -4.1 Million |
| Debt repayment | -12.7 Million | -283.31 Million | -256.37 Million | -612.12 Million | -182.64 Million | -203.42 Million |
| Dividends payments | -19.44 Million | -19.44 Million | -19.44 Million | -19.43 Million | -19.41 Million | -18.59 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 1.13 Million |
| Other Financing Activities | -31 Thousand | 329.74 Million | 292.16 Million | 614.56 Million | 243 Million | 216.77 Million |
| Accounts receivables | -8.67 Million | 5.33 Million | -23.62 Million | -18.2 Million | 28.71 Million | -23.67 Million |
| Accounts payables | 12 Million | -22.83 Million | 26.35 Million | 3.17 Million | -7.67 Million | 12.09 Million |
| Inventory | 2.64 Million | -11.22 Million | -46.99 Million | -12.49 Million | -12.93 Million | -20.98 Million |
| Other working capital | 27.15 Million | -12.41 Million | -373 Thousand | -2.33 Million | -21.76 Million | -3.37 Million |
| Cash at beginning of period | 41.28 Million | 74.24 Million | 50.21 Million | 36.34 Million | 57.57 Million | 29.16 Million |
| Cash at end of period | 70.61 Million | 41.28 Million | 74.24 Million | 50.21 Million | 36.34 Million | 57.57 Million |
| Capital Expenditure | -41.23 Million | -51.79 Million | -37.04 Million | -29.32 Million | -34.04 Million | -29.89 Million |
| Effect of forex changes on cash | -3.3 Million | 754 Thousand | -1.37 Million | 1.13 Million | -1.12 Million | -524 Thousand |
| Net cash flow / Change in cash | 29.33 Million | -32.96 Million | 24.03 Million | 13.86 Million | -21.23 Million | 28.4 Million |
| Free Cash Flow | 46.35 Million | -38.48 Million | -5.39 Million | 18.98 Million | 25.3 Million | 17.27 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.41 Million | 752 Thousand | 8.4 Million | 1.27 Million | -8.01 Million | 32.6 Million |
| Depreciation & Amortization | 36.17 Million | 9.2 Million | 9.19 Million | 8.91 Million | 8.87 Million | 34.01 Million |
| Deferred income taxes | -12.04 Million | -5.23 Million | -300 Thousand | 387 Thousand | -2.69 Million | -2.83 Million |
| Stock-based compensation | 475 Thousand | 179 Thousand | 135 Thousand | 80 Thousand | 81 Thousand | - |
| Change in working capital | 33.11 Million | 20.89 Million | -10.26 Million | 19.4 Million | 3.08 Million | -41.13 Million |
| Other non-cash items | 94.32 Million | 20.5 Million | 35.82 Million | 1.5 Million | 14.86 Million | 1.06 Million |
| Investing Cash Flow | -48.19 Million | -9.11 Million | 1.13 Million | -24.86 Million | -15.35 Million | -74.01 Million |
| Investments in PPE | -41.23 Million | -13.07 Million | -9.73 Million | -10.95 Million | -7.47 Million | -51.79 Million |
| Acquisitions | -3.28 Million | - | 44 Thousand | -3.32 Million | - | 51.79 Million |
| Investment purchases | -65.52 Million | - | -6 Million | -42.52 Million | -17 Million | -40 Million |
| Sales/Maturities of investments | 61.52 Million | 4.52 Million | 17 Million | 31 Million | 9 Million | 17 Million |
| Other Investing Activities | 326 Thousand | -562 Thousand | -183 Thousand | 947 Thousand | 124 Thousand | -51.01 Million |
| Financing Cash Flow | -6.76 Million | 1.78 Million | 4.85 Million | -14.7 Million | 1.29 Million | 26.98 Million |
| Debt repayment | -12.7 Million | -4.01 Million | -8.89 Million | -50.1 Million | -43.1 Million | -283.31 Million |
| Dividends payments | -19.44 Million | -4.86 Million | -4.86 Million | -4.86 Million | -4.86 Million | -19.44 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -31 Thousand | 2.62 Million | 819 Thousand | 40.26 Million | 49.26 Million | 329.74 Million |
| Accounts receivables | -8.67 Million | -11.72 Million | -11.27 Million | 1.53 Million | 12.78 Million | 5.33 Million |
| Accounts payables | 12 Million | 3.9 Million | -3.44 Million | 6.94 Million | 4.6 Million | -22.83 Million |
| Inventory | 2.64 Million | 8.53 Million | 1.65 Million | -2.54 Million | -5 Million | -11.22 Million |
| Other working capital | 27.15 Million | 20.18 Million | 2.79 Million | 13.46 Million | -12.37 Million | -12.41 Million |
| Cash at beginning of period | 41.28 Million | 50.22 Million | 32.97 Million | 43.15 Million | 41.28 Million | 74.24 Million |
| Cash at end of period | 70.61 Million | 70.61 Million | 50.22 Million | 32.97 Million | 43.15 Million | 41.28 Million |
| Capital Expenditure | -41.23 Million | -13.07 Million | -9.73 Million | -10.95 Million | -7.47 Million | -51.79 Million |
| Effect of forex changes on cash | -3.3 Million | -717 Thousand | -137 Thousand | -2.17 Million | -271 Thousand | 754 Thousand |
| Net cash flow / Change in cash | 29.33 Million | 20.38 Million | 17.25 Million | -10.18 Million | 1.87 Million | -32.96 Million |
| Free Cash Flow | 46.35 Million | 15.35 Million | 1.67 Million | 20.59 Million | 8.72 Million | -38.48 Million |
323410
4205
RGLXY
3694
SATS
4751